| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053965 Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 03/03/2011 | US20110053932 Protein Kinase Inhibitors and Methods for Using Thereof |
| 03/03/2011 | US20110053931 Quinoline compounds and methods of use |
| 03/03/2011 | US20110053911 Tricyclic derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 03/03/2011 | US20110053905 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053898 Topical composition comprising vitamin d analogue and corticosteroids |
| 03/03/2011 | US20110053893 Compounds and compositions as tlr activity modulators |
| 03/03/2011 | US20110053876 macrolides and their use |
| 03/03/2011 | US20110053860 COX-2 function and wound healing |
| 03/03/2011 | US20110053855 Ex vivo cell stimulation |
| 03/03/2011 | US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 03/03/2011 | US20110053841 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 03/03/2011 | US20110053833 Synthetic peptides and their use |
| 03/03/2011 | US20110052741 Composition and Method for Skin Repair |
| 03/03/2011 | US20110052740 Skin Circulation-Improving Agent And Skin Temperature-Elevating Agent |
| 03/03/2011 | US20110052739 Active Ingredient That Stimulates the Proliferation and/or Activity of Fibroblasts |
| 03/03/2011 | US20110052737 Topical skin formulations comprising botanical extracts |
| 03/03/2011 | US20110052733 Herbal compositions for the treatment of mucosal lesions |
| 03/03/2011 | US20110052731 Medicinal plants extract using processing of herbal medicine and composition of skin external application comprising the same |
| 03/03/2011 | US20110052726 Solid-layered bleach compositions and methods of use |
| 03/03/2011 | US20110052719 Dermatological composition that can be used in particular for the care and prevention of eschars |
| 03/03/2011 | US20110052718 Synergistic Phytoceutical Compositions |
| 03/03/2011 | US20110052701 Particulates of a crth2 antagonist |
| 03/03/2011 | US20110052695 Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052693 Method for producing artificial skin |
| 03/03/2011 | US20110052692 Novel hydrogels and uses thereof |
| 03/03/2011 | US20110052691 Sustained Release Systems and Preparation Method Thereof |
| 03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
| 03/03/2011 | US20110052676 Composition For Delaying Cellular Senescence |
| 03/03/2011 | US20110052665 Haemostatic material |
| 03/03/2011 | US20110052663 Hemostatic Sponge with Enzyme and Method of Manufacture |
| 03/03/2011 | US20110052650 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest |
| 03/03/2011 | US20110052646 Polymer adhesive film for directed cellular growth |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052560 Method for Increasing the Activity of the Immune System of a Mammal at Risk of Inflammatory Diseases |
| 03/03/2011 | US20110052557 Phytocomposition having antimicrobial activity |
| 03/03/2011 | US20110052522 Cosmetics comprising cistus plant extracts |
| 03/03/2011 | US20110052519 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails |
| 03/03/2011 | US20110052517 Cosmetic Uses of Modified Stressed Yeast Extracts and Related Compositions |
| 03/03/2011 | US20110052515 Avermectin/benzoyl peroxide compositions for treating affliction of the skin, e.g., rosacea |
| 03/03/2011 | US20110052514 Use of natural active substances in cosmetic or therapeutic compositions |
| 03/03/2011 | US20110052513 Cationic surfactant compounds, use thereof as conditioner, cosmetic treatment method, and cosmetic or pharmaceutical compositions comprising same |
| 03/03/2011 | US20110052506 Stable Aerosol Topical Foams Comprising a Hypochlorite Salt |
| 03/03/2011 | US20110052505 Post-biopsy cavity treatment implants and methods |
| 03/03/2011 | US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 03/03/2011 | DE102009037089A1 Zusammensetzung mit Stämmen von Lactobazillus fermentum Composition with Lactobacillus fermentum strains of |
| 03/03/2011 | CA2769151A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | CA2768653A1 Cosmetic uses of modified stressed yeast extracts and related compositions |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |
| 03/02/2011 | EP2289970A1 Biocompatible polymers, their process of manufacture and compositions containing them |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289549A2 Immunoconjugates for treating cancer |
| 03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
| 03/02/2011 | EP2289512A1 Pharmaceutical foam |
| 03/02/2011 | EP2289506A2 Medicament comprising a C11-C21 alkanoic, alkenoic or alkynoic acid ester and a catechin |
| 03/02/2011 | EP2288600A1 Substituted arylcyclopentenes as prostaglandin ep2 agonists |
| 03/02/2011 | EP2288376A2 Methods of generating and using procollagen |
| 03/02/2011 | EP2288357A1 Compositions comprising red microalgae polysaccharides and metals |
| 03/02/2011 | EP2288355A1 Method and composition for skin inflammation and discoloration |
| 03/02/2011 | EP2288349A1 Therapy regimen for treating acne related diseases |
| 03/02/2011 | EP2288348A1 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion |
| 03/02/2011 | EP2288337A1 Parenteral supplement with traceelem ntsfor treatment of i. a. sirs, burns selenium-defenciencies |
| 03/02/2011 | EP1904432B1 Oligomers of straight-chain and unbranched fatty acids, and medicaments containing the same |
| 03/02/2011 | EP1814871B1 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/02/2011 | EP1686951B1 Combined cosmetic or therapeutic preparation |
| 03/02/2011 | EP1646656B1 Human antibody molecules for il-13 |
| 03/02/2011 | EP1638552B1 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN101983051A Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
| 03/02/2011 | CN101982185A Radish seed extract as well as preparation method and application of radish seed extract |
| 03/02/2011 | CN101982184A Preparation method of taraxacum extract |
| 03/02/2011 | CN101982182A Medicine for treating burn and scald and preparation method thereof |
| 03/02/2011 | CN101982176A Compound sodium selenite-vitamin E oral nano-emulsion preparation for livestock and preparation method thereof |
| 03/02/2011 | CN101628088B Traditional Chinese medicine composition for treating dermatosis |
| 03/02/2011 | CN101014352B Composition comprising neem oil and oil extract of hypericum having healing, repellent and biocidal properties for treating external wounds |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897346 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897161 External medicine for treating dermatitis |
| 03/01/2011 | CA2601999C Method for ameliorating pruritus |
| 03/01/2011 | CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |